Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|15|10|1063-1071
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.15, Iss.10, 2009-04, pp. : 1063-1071
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. :
Pain and Obesity in the Older Adult
Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. :
Microvascular Endothelial Dysfunction in Obesity and Hypertension
Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. :
Irbesartan is effective in hypertension associated with obesity
Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. :
Obesity-Induced Hypertension: New Insights
Current Pharmaceutical Design, Vol. 23, Iss. 31, 2017-12 ,pp. :